Summary
Increased hexose uptake is a marker for viral transformation, as has been shown in non-human fibroblasts transformed by oncogenic viruses. If this phenomenon is a general expression of viral induced transformation it should also apply on different oncogenic virus-cell systems.
Recently two human EBV-negative lymphoma lines were converted to a stable EBV-positive state by infection with EBV. According to their biochemical and biological properties they enable us to study events associated with EBV-transformation.
We analysed the uptake of (3H) glucosamine and (3H) 2-deoxy-D-glucose into BJAB and Ramos and their EBV-converted sublines and found a clear increase of the rate of uptake of both sugars in the EBV-positive sublines. Control experiments confirmed that the increased uptake was due to alterations on the level of the hexose membrane carriers and not due to increased metabolism.
The observation of increased hexose uptake in the only presently available virus transformed human cell system is a strong argument for the general importance of this transformation-associated membrane change.
Similar content being viewed by others
References
Anderson M, Lindahl T (1976) Epstein-Barr Virus DNA in human lymphoid cell lines: in vitro conversion. Virology 73: 96
Beek WP v, Nilsson K, Klein G, Emmelot P (1979) Cell surface glycoprotein changes in Epstein-Barr Virus-positive and -negative human hematopoietic cell lines. Int J Cancer 23: 464
Butel JS, Brugge JS, Noonan CA (1974) Transformation of primate and rodent cells by temperature-sensitive mutants of SV40. Cold Spring Harbor Symp Quant Biol 39: 25
Clements GB, Klein G, Povey S (1975) Production by EBV infection of an EBNA-positive subline from an EBV-negative human lymphoma cell line without detectable EBV-DNA. Int J Cancer 16: 125
Eckhart W (1974) Properties of temperature-sensitive mutants of Polyoma Virus. Cold Spring Harbor Symp Quant Biol 39: 37
Epstein MA, Achong BG (1979) The relationship of the virus to Burkitt's lymphoma. In: Epstein MA, Achong BG (eds) The Epstein-Barr Virus. Springer, Berlin Heidelberg New York, p 321
Ernberg I (pers commun)
Fresen KO, zur Hausen H (1976) Establishment of EBNA-expressing cell lines by infection of Epstein-Barr Virus genome negative human lymphoma cells with different EBV strains. Int J Cancer 17: 161
Germinario RJ, Kleiman L, Peters S, Oliveira M (1977) Decreased deoxy-D-glucose transport in Friend cells during exposure to inducers of erythroid differentiation. Exp Cell Res 110: 375
Hatanaka M, Huebner RJ, Gilden RV (1969) Alterations in the characteristics of sugar uptake by mouse cells transformed by murine sarcoma viruses. J Natl Cancer Inst 43: 1091
Hatanaka M, Augl C, Gilden RV (1970) Evidence for a functional change in the plasma membrane of murine sarcoma virus-infected mouse embryo cells. Transport and transport-associated phosphorylation of 14C-2-deoxy-D-glucose. J Biol Chem 245: 714
Hatanaka M, Hanafusa H (1970) Analysis of a functional change in membrane in the process of cell transformation by Rous sarcoma virus; Alteration in the characteristics of sugar transport. Virology 41: 647
Hatanaka M, Gilden RV, Kelloff G (1971) Induction of sugar uptake by a hamster pseudotype sarcoma virus. Virology 43: 734
Hatanaka M (1974) Transport of sugars in tumor cell membranes. Biochim Biophys Acta 355: 77
Hinuma Y, Konn M, Yamagushi J, Wudarsky DJ, Blakeslee JR Jr, Grace JT Jr (1967) Immunofluorescence and herpestype virus particles in the P3HR-I Burkitt lymphoma cell line. J Virology 1: 1045
Inui KI, Moller DE, Tillotson LG, Isselbacher K (1979) Stereospecific hexose transport by membrane vesicles from mouse fibroblasts: Membrane vesicles retain increased hexose transport associated with viral transformation. Proc Natl Acad Sci USA 76: 3972
Klein G, Lindahl T, Jondal M, Leibold W, Menézes J, Nilsson K, Sundström C (1974) Continuous lymphoid cell lines with characteristics of B-cells (bone marrow derived) lacking the Epstein-Barr Virus genome and derived from three human lymphomas. Proc Natl Acad Sci USA 71: 3283
Klein G, Giovanella B, Westman A, Stehlin JS, Mumford D (1975) An EBV-genome negative cell line established from an American Burkitt lymphoma; Receptor characteristics, EBV infectivity and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5: 319
Koide N, Wells A, Klein G (1981) Cell surface glycoprotein patterns of two EBV-negative lines and their EBV-converted sublines (in prep)
Martin GS, Venuta S, Weber M, Rubin H (1971) Temperature-dependent alterations in sugar transport in cells infected with a temperature-sensitive mutant of Rous sarcoma virus. Proc Natl Acad Sci USA 68: 2739
McConnell I, Klein G, Lint TF, Lachmann PJ (1978) Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus (EBV) transformation of the cells. Eur J Immunol 8: 453
Menézes J, Leibold W, Klein G, Clements G (1975) Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B-cell line from an exceptional, EBV-genome negative African Burkitt's lymphoma. Biomédicine 22: 276
Miller G, Lipman M (1973) Release of infectious Epstein-Barr virus by transformed marmoset leucocytes. Proc Natl Acad Sci USA 70: 190
Montagnier L, Gruest J (1979) Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after Epstein-Barr Virus conversion. Int J Cancer 23: 71
Nicholson GL (1976) Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy. Biochim Biophys Acta 458: 1
Nilsson K, Giovanella BC, Stehlin JS, Klein G (1977) Tumorigenicity of human hematopoetic cell lines in athymic nude mice. Int J Cancer 19: 337
Siegert W, Mönch T, Valet G (1980) Epstein-Barr Virus-induced increase in the Concanavalin A receptor density of established EBV-negative lymphoma lines in vitro. Exp Hematol 8: 1173
Smets LA (1980) Cell transformation as a model for induction and neoplastic growth. Biochim Biophys Acta 605: 93
Steinitz M, Klein G (1975) Comparison between growth characteristics of an Epstein-Barr virus (EBV)-genome negative lymphoma line and its EBV-converted subline in vitro. Proc Natl Acad Sci USA 72: 3518
Steinitz M, Klein G (1976) Epstein-Barr Virus (EBV)-induced change in the saturation sensitivity and serum dependence of established, EBV-negative lymphoma lines in vitro. Virology 70: 570
Steinitz M, Klein G (1977) Further studies on the differences in the serum dependence in EBV-negative lymphoma lines and their in vitro EBV-converted, virus genome carrying sublines. Eur J Cancer 13: 1269
Venuta S, Rubin H (1973) Sugar transport in normal and in Rous sarcoma virus-transformed chick-embryo fibroblasts. Proc Natl Acad Sci USA 70: 653
Weber JM (1973) Hexose transport in normal and in Rous sarcoma virus transformed cells. J Biol Chem 218: 2978
Yefenof E, Klein G (1974) Antibody-induced redistribution of normal and tumor associated surface antigens. Exp Cell Res 88: 217
Yefenof E, Klein G (1976) Difference in antibody induced redistribution of membrane IgM in EBV genome free and EBV-positive human lymphoid cells. Exp Cell Res 99: 175
Yefenof E, Klein G, Ben-Bassat H, Lundin L (1977) Differences in the Con-A induced redistribution and agglutination patterns of EBV-genome free and EBV-carrying human lymphoma lines. Exp Cell Res 108: 185
Zech L, Haglund K, Nilsson K, Klein G (1976) Characteristic chromosomal abnormalities in biopsies and lymphoid cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 17: 47
Author information
Authors and Affiliations
Additional information
Supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 37 (W.S., G10)
Rights and permissions
About this article
Cite this article
Siegert, W., Mönch, T. Hexose transport in epstein-barr virus (EBV) negative lymphoma lines and their EBV converted, virus genome carrying sublines. Blut 43, 297–305 (1981). https://doi.org/10.1007/BF00320953
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320953